Abcam ( OTCMKTS:ABCZF – Get Rating ) is one of 350 publicly-traded companies in the 'Biotechnology' industry, but how does it contrast to its peers? We will compare Abcam to related businesses based on the strength of its risk, valuation, institutional ownership, analyst recommendations, dividends, profitability and earnings. Insider and Institutional Ownership 43.6% of Abcam shares are owned by institutional investors. Comparatively, 24.6% of shares of all 'Biotechnology' companies are owned by institutional investors.

https://www.dailypolitical.com/2023/06/20/reviewing-abcam-abczf-and-its-competitors.html

#dailypolitical